Intervacc AB (OSTO:IVACC) Capital Expenditure : kr-1.41 Mil (TTM As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Intervacc AB Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Intervacc AB's cash flow for capital expenditures for the three months ended in Mar. 2024 was kr-0.14 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Mar. 2024 was kr-1.41 Mil.

Intervacc AB Capital Expenditure Historical Data

The historical data trend for Intervacc AB's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Intervacc AB Capital Expenditure Chart

Intervacc AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Capital Expenditure

Get a 7-Day Free Trial

-39.50

-11.42

-23.21

-6.13

-2.11

Intervacc AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Capital Expenditure	Get a 7-Day Free Trial															-0.84	-0.54	-0.59	-0.14	-0.14

Intervacc AB Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-1.41 Mil.

Intervacc AB (OSTO:IVACC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Intervacc AB (OSTO:IVACC) » Definitions » Capital Expenditure

Comparable Companies

Traded in Other Exchanges

2E9:Germany

Address

Vastertorpsvagen 135, Hagersten, Stockholm, SWE, S-129 44

Website

https://www.intervacc.se

Intervacc AB is a biotechnology company. It develops new vaccines based on recombinant proteins to meet the increasing need for effective vaccines in animal health care. The company through its subsidiary focuses on diagnostics in the Swedish animal health market and offers bacteriological and mycological analyses on the Swedish market.

Intervacc AB (OSTO:IVACC) Headlines

No Headlines